Grassley’s tweet can be found HERE.
Congress Must
Address Drug Prices in Relief Legislation
Prepared Floor
Remarks by U.S. Senator Chuck Grassley of Iowa
Chairman, Senate Finance
Committee
Wednesday, July
22, 2020
According
to a recent Gallup poll, nine out of ten
Americans are concerned about prescription drug prices. Specifically, they are
concerned that the pharmaceutical industry will take advantage of the current
pandemic to hike drug prices.
That
poll was published a month ago. Unfortunately, those concerns have become a
reality.
Two
weeks ago, Politico reported that
pharmaceutical companies have raised prices on hundreds of prescription drugs
during the pandemic. The report says that there have been more than 800 –eight hundred
– price increases just this year.
I’ve
been working on a bill for over a year and a half to stem these increases and
rein in drug prices. It would cap costs for Medicare recipients, cap increases
to the rate inflation and save taxpayers nearly 100 billion dollars.
It
wasn’t simple, but I’m glad to have produced that kind of bill with Ranking
Member Wyden and my colleagues here with me today.
But
I’m disappointed.
My
partner and all of my Democratic colleagues who approved this bill in committee
declined to cosponsor an improved version of the bill that they helped put
together. I can’t be sure why, but I have to assume it’s because it’s an
election year. And that passing a bill that would do so much good, in a time of
so much hardship, might help Republicans who also support the bill, hurting
Democrat chances of taking the majority.
As
we consider a new relief bill, we ought to put aside that kind of
politics-before-people legislating. We need to approve the Prescription Drug
Pricing Reduction Act as part of this package.
Our
country is facing the most serious public health crisis in generations.
Millions of Americans are newly unemployed and many small businesses have
slowed or shuttered altogether. People across the country are stretching their
paychecks and savings to get through the pandemic.
In
the CARES Act and subsequent legislation, we helped slow the hurt from
this virus. But there’s only so much a stimulus check or tax relief can do when
your bills just keep going up.
These
drug price increases are a weight that Americans just shouldn’t have to bear,
especially seniors on whom the virus is taking a particular toll. The increases
aren’t a result of a functioning marketplace or an industry with healthy
competition.
Addressing
these price increases is also something we all, largely, agree on.
In
2016, the president campaigned on making the marketplace for prescription drugs
fairer and more affordable for patients. He won.
In
2018, many House Democrats campaigned on making the marketplace for
prescription drugs fairer and more affordable. Many of them won. And they took
over the House.
It’s
time to put politics aside and finally act.
Just
because Big Pharma was bankrupting patients before the pandemic, doesn’t mean
we should allow them to keep doing it now. In fact, there’s no better time to
put an end to Big Pharma’s price gouging than now.
-30-